Clinical Trials Browser

INDUSTRY × Diphenhydramine × Other hematologic neoplasm × Clear all

NCT04580121 2024-06-03

A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02999633 2022-03-21

ISLAY

Phase 2 Terminated

14 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma